The rational combination of BRAF inhibition with immunotherapy for the treatment of metastatic melanoma

被引：0
|
作者：
Lizee, Gregory [1 ]
Liu, Chengwen [1 ]
Hwu, Patrick [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-PL03-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL03-03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma
    Dimitrios C. Ziogas
    Frosso Konstantinou
    Spyros Bouros
    Maria Theochari
    Helen Gogas
    American Journal of Clinical Dermatology, 2021, 22 : 301 - 314
  • [2] Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma
    Ziogas, Dimitrios C.
    Konstantinou, Frosso
    Bouros, Spyros
    Theochari, Maria
    Gogas, Helen
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (03) : 301 - 314
  • [3] BRAF Inhibition for metastatic Melanoma
    Hauschild, A.
    HNO, 2019, 67 (04) : 238 - 238
  • [4] Immunotherapy vs BRAF and MEK inhibitors in the treatment of metastatic melanoma
    Casas Hidalgo, I.
    Nieto Gomez, P.
    Rodriguez Delgado, A.
    Alvarez Sanchez, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 376 - 376
  • [5] Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
    Welsh, Sarah J.
    Rizos, Helen
    Scolyer, Richard A.
    Long, Georgina V.
    EUROPEAN JOURNAL OF CANCER, 2016, 62 : 76 - 85
  • [6] Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma
    Queirolo, Paola
    Picasso, Virginia
    Spagnolo, Francesco
    CANCER TREATMENT REVIEWS, 2015, 41 (06) : 519 - 526
  • [7] Vemurafenib and BRAF Inhibition: A New Class of Treatment for Metastatic Melanoma
    Luke, Jason J.
    Hodi, F. Stephen
    CLINICAL CANCER RESEARCH, 2012, 18 (01) : 9 - 14
  • [8] Rational combination of cancer immunotherapy in melanoma
    Mario Mandalà
    Piotr Rutkowski
    Virchows Archiv, 2019, 474 : 433 - 447
  • [9] Rational combination of cancer immunotherapy in melanoma
    Mandala, Mario
    Rutkowski, Piotr
    VIRCHOWS ARCHIV, 2019, 474 (04) : 433 - 447
  • [10] Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
    Flaherty, Keith T.
    Puzanov, Igor
    Kim, Kevin B.
    Ribas, Antoni
    McArthur, Grant A.
    Sosman, Jeffrey A.
    O'Dwyer, Peter J.
    Lee, Richard J.
    Grippo, Joseph F.
    Nolop, Keith
    Chapman, Paul B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09): : 809 - 819
12345